How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management? / Ashina, Sait; Olesen, Jes; Lipton, Richard B.

I: Current Pain and Headache Reports, Bind 20, Nr. 12, 66, 2016.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Ashina, S, Olesen, J & Lipton, RB 2016, 'How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?', Current Pain and Headache Reports, bind 20, nr. 12, 66. https://doi.org/10.1007/s11916-016-0599-z

APA

Ashina, S., Olesen, J., & Lipton, R. B. (2016). How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management? Current Pain and Headache Reports, 20(12), [66]. https://doi.org/10.1007/s11916-016-0599-z

Vancouver

Ashina S, Olesen J, Lipton RB. How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management? Current Pain and Headache Reports. 2016;20(12). 66. https://doi.org/10.1007/s11916-016-0599-z

Author

Ashina, Sait ; Olesen, Jes ; Lipton, Richard B. / How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?. I: Current Pain and Headache Reports. 2016 ; Bind 20, Nr. 12.

Bibtex

@article{c48f119de2e4418a9468a37b797ca4ea,
title = "How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?",
abstract = "Classification has played a major role in the diagnosis of primary headache conditions including migraine with and without aura. With many updates and changes, the International Classification of Headache Disorders (ICHD)-3 beta is currently considered as the gold standard for classification of migraine and other headaches. Correct diagnosis of migraine and its subtypes is a first step toward appropriate treatment and crucial to minimizing disability and optimizing health-related quality of life. The ICHD-3 beta version represents the state of the art in migraine diagnosis but is expected to evolve as biological knowledge advances. Future research should focus on identification of biologically homogeneous subgroups of migraine based on genes and biomarkers.",
keywords = "Classifications, Diagnosis, ICHD, Management, Migraine",
author = "Sait Ashina and Jes Olesen and Lipton, {Richard B}",
year = "2016",
doi = "10.1007/s11916-016-0599-z",
language = "English",
volume = "20",
journal = "Current Pain and Headache Reports",
issn = "1531-3433",
publisher = "Springer Healthcare",
number = "12",

}

RIS

TY - JOUR

T1 - How Well Does the ICHD 3 (Beta) Help in Real-Life Migraine Diagnosis and Management?

AU - Ashina, Sait

AU - Olesen, Jes

AU - Lipton, Richard B

PY - 2016

Y1 - 2016

N2 - Classification has played a major role in the diagnosis of primary headache conditions including migraine with and without aura. With many updates and changes, the International Classification of Headache Disorders (ICHD)-3 beta is currently considered as the gold standard for classification of migraine and other headaches. Correct diagnosis of migraine and its subtypes is a first step toward appropriate treatment and crucial to minimizing disability and optimizing health-related quality of life. The ICHD-3 beta version represents the state of the art in migraine diagnosis but is expected to evolve as biological knowledge advances. Future research should focus on identification of biologically homogeneous subgroups of migraine based on genes and biomarkers.

AB - Classification has played a major role in the diagnosis of primary headache conditions including migraine with and without aura. With many updates and changes, the International Classification of Headache Disorders (ICHD)-3 beta is currently considered as the gold standard for classification of migraine and other headaches. Correct diagnosis of migraine and its subtypes is a first step toward appropriate treatment and crucial to minimizing disability and optimizing health-related quality of life. The ICHD-3 beta version represents the state of the art in migraine diagnosis but is expected to evolve as biological knowledge advances. Future research should focus on identification of biologically homogeneous subgroups of migraine based on genes and biomarkers.

KW - Classifications

KW - Diagnosis

KW - ICHD

KW - Management

KW - Migraine

U2 - 10.1007/s11916-016-0599-z

DO - 10.1007/s11916-016-0599-z

M3 - Review

C2 - 27873122

AN - SCOPUS:84996598609

VL - 20

JO - Current Pain and Headache Reports

JF - Current Pain and Headache Reports

SN - 1531-3433

IS - 12

M1 - 66

ER -

ID: 179124735